Cargando…

Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source

BACKGROUND: The trans-fat containing AMLN (amylin liver non-alcoholic steatohepatitis, NASH) diet has been extensively validated in C57BL/6J mice with or without the Lep(ob)/Lep(ob) (ob/ob) mutation in the leptin gene for reliably inducing metabolic and liver histopathological changes recapitulating...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boland, Michelle L, Oró, Denise, Tølbøl, Kirstine S, Thrane, Sebastian T, Nielsen, Jens Christian, Cohen, Taylor S, Tabor, David E, Fernandes, Fiona, Tovchigrechko, Andrey, Veidal, Sanne S, Warrener, Paul, Sellman, Bret R, Jelsing, Jacob, Feigh, Michael, Vrang, Niels, Trevaskis, James L, Hansen, Henrik H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Basic Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737317/ https://www.ncbi.nlm.nih.gov/pubmed/31543682 http://dx.doi.org/10.3748/wjg.v25.i33.4904

Ejemplares similares

Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
por: Tølbøl, Kirstine S, et al.
Publicado: (2018)

INT-767 improves histopathological features in a diet-induced ob/ob mouse model of biopsy-confirmed non-alcoholic steatohepatitis
por: Roth, Jonathan D, et al.
Publicado: (2018)

Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH
por: Møllerhøj, Mathias B., et al.
Publicado: (2022)

Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis
por: Tølbøl, Kirstine S., et al.
Publicado: (2018)

Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH
por: Baandrup Kristiansen, Maria Nicoline, et al.
Publicado: (2019)

Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis
por: Hansen, Henrik H., et al.
Publicado: (2020)

Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis
por: Ægidius, Helene M., et al.
Publicado: (2020)

Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH
por: Roth, Jonathan D., et al.
Publicado: (2019)

Both Elafibranor and Liraglutide Improve NAFLD / NASH but Affect Differentially the Hepatic Lipidome and Metabolome in a Diet-Induced Obese and Biopsy-Confirmed Mouse Model of NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
por: Boland, Michelle L, et al.
Publicado: (2018)

Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH
por: Perakakis, Nikolaos, et al.
Publicado: (2021)

The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis
por: Perakakis, Nikolaos, et al.
Publicado: (2020)

Microbial burden and viral exacerbations in a longitudinal multicenter COPD cohort
por: Bouquet, Jerome, et al.
Publicado: (2020)

Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice
por: Sembach, Frederikke E., et al.
Publicado: (2019)

Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function
por: Jones-Nelson, Omari, et al.
Publicado: (2020)

The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice
por: Cucak, Helena, et al.
Publicado: (2016)

Resolution of NASH and hepatic fibrosis by the GLP-1R/GcgR dual-agonist Cotadutide via modulating mitochondrial function and lipogenesis.
por: Boland, Michelle L., et al.
Publicado: (2020)

Evaluation of safety for hepatectomy in a novel mouse model with nonalcoholic-steatohepatitis
por: Ozawa, Yusuke, et al.
Publicado: (2018)

Gut dysbiosis and systemic inflammation promote cardiomyocyte abnormalities in an experimental model of steatohepatitis
por: Longo, Larisse, et al.
Publicado: (2021)

Alterations in hypothalamic gene expression following Roux-en-Y gastric bypass
por: Barkholt, Pernille, et al.
Publicado: (2016)

S. aureus Evades Macrophage Killing through NLRP3-Dependent Effects on Mitochondrial Trafficking
por: Cohen, Taylor S., et al.
Publicado: (2018)

DNA methylation of angiotensin II receptor gene in nonalcoholic steatohepatitis-related liver fibrosis
por: Asada, Kiyoshi, et al.
Publicado: (2016)

Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis
por: Haldrup, David, et al.
Publicado: (2018)

Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis
por: Klaikeaw, Naruemon, et al.
Publicado: (2020)

Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission
por: Pehrson, Alan L., et al.
Publicado: (2018)

A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents
por: Dalbøge, Louise S., et al.
Publicado: (2015)

Associations of pathogen‐specific and host‐specific characteristics with disease outcome in patients with Staphylococcus aureus bacteremic pneumonia
por: Sharma‐Kuinkel, Batu K, et al.
Publicado: (2019)

Characterisation of Age-Dependent Beta Cell Dynamics in the Male db/db Mice
por: Dalbøge, Louise S., et al.
Publicado: (2013)

Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats
por: Hansen, Carl Frederik, et al.
Publicado: (2013)

3D quantification of changes in pancreatic islets in mouse models of diabetes type I and II
por: Roostalu, Urmas, et al.
Publicado: (2020)

Differential Expression and Roles of Staphylococcus aureus Virulence Determinants during Colonization and Disease
por: Jenkins, Amy, et al.
Publicado: (2015)

Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis
por: Ye, Jian-Zhong, et al.
Publicado: (2018)

Confirming longline position in neonates - Survey of practice in England and Wales
por: Arunoday, Arunoday, et al.
Publicado: (2017)

Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats
por: Zhao, Ze-Hua, et al.
Publicado: (2019)

Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
por: Fernández-Ramos, David, et al.
Publicado: (2020)

Folic acid attenuates high-fat diet-induced steatohepatitis via deacetylase SIRT1-dependent restoration of PPARα
por: Xin, Feng-Zhi, et al.
Publicado: (2020)

Tumor necrosis factor alpha receptor 1 deficiency in hepatocytes does not protect from non-alcoholic steatohepatitis, but attenuates insulin resistance in mice
por: Bluemel, Sena, et al.
Publicado: (2020)

Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis
por: Ilan, Yaron, et al.
Publicado: (2016)

Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis
por: Nestor, John J., et al.
Publicado: (2022)

PPARGC1A rs8192678 G>A polymorphism affects the severity of hepatic histological features and nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
por: Zhang, Rui-Nan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hjm4f5lu1tk1on2lu2srdf73va